Clinical Study to Investigate the Safety and Pharmacokinetics of Mirodenafil Tablet in Renal Impaired Male Patients

Trial Profile

Clinical Study to Investigate the Safety and Pharmacokinetics of Mirodenafil Tablet in Renal Impaired Male Patients

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2015

At a glance

  • Drugs Mirodenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top